NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Quarter ending 2026-12-30 | ||
| Revenue | — | 7,584 |
| EPS | — | 0.385 |
| Annual ending 2026-12-31 | ||
| Revenue | — | 0 |
| EPS | — | -11.473 |
Management figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Progress in AI capabilities development | A primary condition in AUDDIA INC's published investment case. The stated target is Significant progress toward first AI datacenter deployment by end 2026. | Intact | No meaningful AI deployment progress by end 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Effective capital allocation to support growth and stability | A supporting condition in AUDDIA INC's published investment case. The stated target is Manage capital raises without excessive dilution through 2026. | Under Pressure | Excessive dilution or poor capital use harming shareholder value | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 quarters including 2026-Q1 and 2026-Q2. Management requires at least $12 million net cash at merger closing to provide runway for future milestones. Financials show operating losses and negative net income, underscoring the importance of capital management. The trajectory is consistent with management's stated capital allocation focus. Delivery assessment Oct 24, 2026 |
Improvement in earnings toward profitability | A primary condition in AUDDIA INC's published investment case. The stated target is Reduce EPS losses significantly toward breakeven by FY27. | Broken | EPS remains below -$1.49 or worsens in FY27 | Diluted EPS: $-0.71 per share FY2026-Q2; GAAP. Published target: Reduce EPS losses significantly toward breakeven by FY27. Target period is not explicitly aligned with this observation. Source published Aug 14, 2026-0.71 USD/share · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: b9fbf5e2-2cfa-4c61-8778-f274a8a7a867. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Successful M&A to enhance capabilities and market position | The company actively pursues M&A to strengthen its market position. | Improving | No material M&A activity by end 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 quarters including 2026-Q1 and 2026-Q2. Management has actively pursued and completed acquisition activities including the merger agreement with Thramann Holdings. The financials and disclosures confirm the merger progress, indicating delivery on this M&A priority. Delivery assessment Oct 24, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 5, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth and merger-dependent situation, not an established compounder. The long-term thesis is in a watch state: management is pursuing the merger and AI initiatives, but execution is mixed and recent financial performance is weak.
The valuation model has low confidence and shows AUUD at a 131.9% premium versus peers, with optionality as the main reason for the gap. That suggests substantial expectations for future opportunities are already reflected, though the evidence does not specify exactly what the market assumes. The priced-in fragility assessment is low, but that does not remove the business and execution risks.
Near term, losses, a record of recent earnings misses, and elevated miss risk point to continued pressure on operating results. Management has kept the merger, AI subsidiaries, and financing among its priorities, but the merger is not closed and requires at least $12 million in net cash at closing. Two recent acquisition-completion updates are positive, while management's score has fallen and overall execution remains mixed.
Over the multi-year view, the central question is whether the Thramann merger closes and provides the resources to advance LT350, Influence Healthcare, and Voyex. The thesis also depends on securing the required cash and showing that these AI initiatives can make concrete progress. Near-term sector support could improve if the Fed cuts rates or major technology companies keep reporting strong results; weaker results from those companies could remove that support.
AUUD's 1-to-3-year case rests on merger completion, financing, and progress in its AI businesses, while losses and execution risk remain high. The evidence supports a cautious watch thesis, not a proven operating turnaround. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.